Jason Empson
Nurse Practitioner · Coos Bay, ORNPI 1770255283
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (34.9%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Urogen Pharma, Inc. at 45.0% of the total. Reporting peaked in 2023 at $1,629 and has fallen 91.5% since, to $138 in 2025. Among nurse practitioner clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 31 payments — averaging $61.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Urogen Pharma, Inc.$862
- Teleflex LLC$716
- Tolmar, Inc.$68
- Astellas Pharma US Inc$65
- AbbVie$39
- Bayer$33
- plus $132 from 7 others
What the payments were for
- Speaking & faculty fees$62533%
- Travel & lodging$66835%
- Food & beverage$62333%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Urogen Pharma, Inc. | 4 | $862 |
| Teleflex LLC | 9 | $716 |
| Tolmar, Inc. | 3 | $68 |
| Astellas Pharma US Inc | 4 | $65 |
| AbbVie | 2 | $39 |
| Bayer | 2 | $33 |
| Myriad Genetic Laboratories, Inc. | 1 | $27 |
| Coloplast | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $21 |
| Progenics Pharmaceuticals, Inc. | 1 | $19 |
| Laborie Medical Technologies Corp. | 1 | $15 |
| Boston Scientific | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,916 in reported general payments places this provider in the 95th percentile of 997 nurse practitioner providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 117 | $76,510 |
| GemtesaVibegron | 40 | $32,647 |
| Tamsulosin Hcl | 622 | $14,305 |
| Potassium Citrate ErPotassium Citrate | 14 | $6,356 |
| Testosterone Cypionate | 81 | $3,126 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 116 | $2,877 |
| Finasteride | 182 | $2,363 |
| Oxybutynin Chloride | 117 | $2,120 |
| Dutasteride | 38 | $1,784 |
| Methenamine Hippurate | 11 | $1,669 |
| Terazosin Hcl | 50 | $1,411 |
| Oxybutynin Chloride ErOxybutynin Chloride | 53 | $1,337 |
| CefuroximeCefuroxime Axetil | 70 | $1,105 |
| Solifenacin Succinate | 31 | $1,074 |
| Estradiol | 23 | $1,036 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $65 | $76,510117 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $15 | $32,64740 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 997 nurse practitioner providers in Oregon.
Other nurse practitioner in Coos Bay
- Margaret McLainCoos Bay$8K
- Davina BledsoeCoos Bay$2K
- Alicia DuyvejonckSpringfield$299K
- Summer HarnessLake Oswego$113K
- Alana WilsonPortland$58K
- Jennifer MurdochPortland$15K
- Berhane MebratuPortland$10K
- Desiree CihelkaSpringfield$8K
- Amy CarterPortland$8K
- Mallory CrownoverSpringfield$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.